Harlequin: A Therapeutic Sativa-Dominant Hybrid

Harlequin is a sativa-dominant hybrid strain with a 25:75 indica/sativa ratio, created from a cross between Colombian Gold, Thai, and Swiss Landrace. This strain is notable for its balanced CBD to THC ratio, approximately 1:1, making it a popular choice for those seeking therapeutic benefits without strong psychoactive effects. Harlequin is recognized for its unique flavor and aroma, featuring notes of mango and earthy musk.

This strain is best known for its relaxing and calming properties, while still allowing users to remain focused and alert. Physically, Harlequin is dense with thick nugs, heavily coated in trichomes. Although it has mild side effects, such as dry mouth and eyes, and occasionally slight nausea or headaches, these are typically minimal.

Harlequin is often grown indoors, with a flowering time of 60 to 70 days, and it is highly regarded for its effectiveness in relieving pain, whether related to muscles, body aches, or headaches. The low THC content also makes it an ideal choice for patients who need to stay clear-headed while managing pain.